Home/Filings/4/0001127602-24-014594
4//SEC Filing

Lingamneni Anila 4

Accession 0001127602-24-014594

CIK 0000313143other

Filed

May 7, 8:00 PM ET

Accepted

May 8, 4:21 PM ET

Size

4.8 KB

Accession

0001127602-24-014594

Insider Transaction Report

Form 4
Period: 2024-05-06
Lingamneni Anila
EVP, Chief Technology Officer
Transactions
  • Sale

    Common Stock

    2024-05-06$95.00/sh2,305$218,97512,295 total
Footnotes (2)
  • [F1]Transaction pursuant to an existing 10b5-1 trading plan dated June 2, 2023 (fully executed as of June 5, 2023).
  • [F2]This number includes unvested restricted stock units previously reported as well as 289 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2024.

Issuer

HAEMONETICS CORP

CIK 0000313143

Entity typeother

Related Parties

1
  • filerCIK 0001808414

Filing Metadata

Form type
4
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:21 PM ET
Size
4.8 KB